摘要 |
There are provided in accordance with the present invention crystalline forms A, B, C, F, G, I, J, P, and Q of efaproxiral sodium. Also provided is the amorphous form of efaproxiral sodium. Also provided are methods of forming the novel polymorphs and the amorphous form of efaproxiral sodium, therapeutic methods utilizing them and pharmaceutical dosage forms containing them. |
申请人 |
ALLOS THERAPEUTICS, INC.;JOHNSON, DOUGLAS, G.;MURRAY, CHRIS;PARENT, STEPHAN, D.;JONAITIS, DAVID, T. |
发明人 |
JOHNSON, DOUGLAS, G.;MURRAY, CHRIS;PARENT, STEPHAN, D.;JONAITIS, DAVID, T. |